salicin,
salicyl alcohol glucoside,
salicin,
138-52-3,
Salicoside,
Salicine,
Salicyl alcohol glucoside,
D-(-)-Salicin,
(2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-(2-(hydroxymethyl)phenoxy)tetrahydro-2H-pyran-3,4,5-triol,
2-(Hydroxymethyl)phenyl beta-D-glucopyranoside,
Saligenin beta-D-glucopyranoside,
D-Salicin,
Saligenin-beta-D-glucopyranoside,
D(-)-Salicin,
2-(Hydroxymethyl)phenyl-beta-d-glucopyranoside,
Salicin (6CI,8CI),
MFCD00006590,
o-(Hydroxymethyl)phenyl beta-D-glucopyranoside,
Benzyl alcohol, o-hydroxy-, o-glucoside,
UNII-4649620TBZ,
AI3-19099,
alpha-Hydroxy-o-tolyl beta-D-glucopyranoside,
NSC 5751,
EINECS 205-331-6,
SPECTRUM1502255,
B-D-Glucopyranoside, 2-(hydroxymethyl)phenyl,
CHEBI:17814,
beta-D-Glucopyranoside, 2-(hydroxymethyl)phenyl,
D-()-Salicin,
4649620TBZ,
SDCCGMLS-0066698.P001,
NCGC00142605-01,
D(-)-Salicin, 99+%,
(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[2-(hydroxymethyl)phenoxy]oxane-3,4,5-triol,
(2S,4S,5S,3R,6R)-6-(hydroxymethyl)-2-[2-(hydroxymethyl)phenoxy]-2H-3,4,5,6-tet rahydropyran-3,4,5-triol,
SMR000112301,
Salicin [USP],
SR-05000001594,
delta-Salicin,
Salicoside,Salicine,
AK-58886,
Spectrum_001230,
Spectrum2_000756,
Spectrum3_000948,
Spectrum4_001058,
Spectrum5_000971,
bmse000315,
Salicin from Plant Extract,
Salicyl alcohol-b-glucoside,
SCHEMBL24936,
KBioGR_001356,
KBioSS_001710,
Saligenin-b-D-glucopyranoside,
KSC914S4F,
MLS000563050,
MLS001306490,
DivK1c_000030,
S0625_SIGMA,
Salicin(Salicoside,-Salicine),
SPBio_000772,
AC1L97H8,
CHEMBL462997,
MEGxp0_000685,
Salicin (Salicoside, Salicine),
ACon1_000373,
CTK8B4942,
HMS500B12,
KBio1_000030,
KBio2_001710,
KBio2_004278,
KBio2_006846,
KBio3_002016,
BIK9020,
NGFMICBWJRZIBI-UJPOAAIJSA-N,
NINDS_000030,
HMS1921P08,
HMS2092F14,
HMS2268J11,
Pharmakon1600-01502255,
EBD45938,
HY-N0149,
Saligenin beta-delta-glucopyranoside,
Saligenin-beta-delta-glucopyranoside,
ZINC3847505,
D-(-)-Salicin, analytical standard,
Salicoside, Salicine, 138-52-3,
ANW-46774,
CCG-40332,
CS0013,
NSC758201,
s2351,
SBB012498,
ZINC03847505,
AKOS004907439,
AC-8042,
API0004125,
CS-8027,
D-(-)-Salicin, >=99% (GC),
MCULE-4540152608,
MCULE-8469382160,
NSC-758201,
RTR-031159,
IDI1_000030,
NCGC00142605-02,
NCGC00142605-04,
AJ-45866,
CJ-10812,
LS-71545,
SC-11370,
ST069327,
SBI-0051746.P002,
AX8002670,
ST2414222,
2(hydroxymethyl)phenyl-beta-D-glucopyranoside,
FT-0603347,
N1880,
S0003,
SW219123-1,
A-8126,
C01451,
2-(Hydroxymethyl)-phenyl-beta-D-glucopyranoside,
2-(hydroxymethyl)phenyl-O-beta-D-glucopyranoside,
AB00052296_07,
beta-D-Glucopyranoside, 2-(hydroxymethyl)phenyl-,
138S523,
SR-05000001594-1,
SR-05000001594-2,
BRD-K64614248-001-02-4,
BRD-K64614248-001-06-5,
EAD32BE1-198E-432C-9F44-DC0DC9A3305B,
Salicin, European Pharmacopoeia (EP) Reference Standard,
D-Salicin, United States Pharmacopeia (USP) Reference Standard,
(2R,3S,4S,5R,6S)-2-(Hydroxymethyl)-6-(2-(hydroxymethyl)-phenoxy)tetrahydro-2H-pyran-3,4,5-triol,
SA0,
D(?)-Salicin,
D06BQU,
C8H10O,
C13H18O7,
Salicin 99% for microbiology 5gm,
CID439503,
2-(Hydroxymethyl)phenyl hexopyranoside,
?-Hydroxy-o-tolyl-?-D-glucopyranoside,
ACN-035619,
C13-H18-O7,
D-(-)-Salicin, 98% - 5G 5g,
A10820,
.beta.-D-Glucopyranoside, 2-(hydroxymethyl)phenyl,
C005696,